Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1344-95-2
2. Micro-cel
3. Dicalcium;silicate
4. Calcium Silicate [nf]
5. Calsil
6. Calcium Silicate (nf)
7. Cs Lafarge
8. Toyofine A
9. Florite R
10. Microcal Et
11. Starlex L
12. Calflo E
13. Silmos T
14. Silene Ef
15. Micro-cel A
16. Micro-cel B
17. Micro-cel C
18. Micro-cel E
19. Micro-cel T
20. Promaxon P60
21. Calcium Monosilicate
22. Calcium Polysilicate
23. Stabinex Nw 7ps
24. Marimet 45
25. Micro-cel T26
26. Micro-cel T38
27. Micro-cel T41
28. Microcal 160
29. Calcium Hydrosilicate
30. Silicic Acid Calcium Salt
31. Hsdb 705
32. Einecs 215-710-8
33. Sw 400
34. Calcium Silicate, Synthetic Nonfibrous
35. Calcium Silicate, Synthetic
36. Unii-s4255p4g5m
37. Dicalcium Orthosilicate
38. Ec 215-710-8
39. Dtxsid5049570
40. Nsc 57629
41. Akos015915657
42. D03309
43. Q416365
44. 39433-03-9
| Molecular Weight | 172.24 g/mol |
|---|---|
| Molecular Formula | Ca2O4Si |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 171.8817667 g/mol |
| Monoisotopic Mass | 171.8817667 g/mol |
| Topological Polar Surface Area | 92.2 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 19.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Calcium Silicate is listed in the OTC Active Ingredient Status Report as an external analgesic and skin protectant.
Elmore AR; Cosmetic Ingredient Review Expert Panel; J Am Coll Toxicol 22 (Suppl. 1): 37-102 (2003)
MEDICATION (VET): ... /IT/ HAS ANTACID & ADSORBENT PROPERTIES SIMILAR TO MAGNESIUM SILICATES.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 72
The substance can be absorbed into the body by inhalation.
International Program on Chemical Safety/Commission of the European Communities; International Chemical Safety Card on Calcium silicate (May 2001). Available from, as of May 20, 2010: https://www.inchem.org/pages/icsc.html
The biodurability of various glass fibers, rockwool, and ceramic fibers was examined in rat lungs and compared with natural mineral fibers ... Sized fractions of fibers were instilled intratracheally into Wistar rats ... The half-time of fiber elimination from the lung ranges from about 10 days for wollastonite to more than 300 days for crocidolite. The biodurability of man-made vitreous fibers (MMVF) is between these values and is dependent on the chemical composition of the fibers and the diameter and length distribution ...
PMID:7882923 Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567280 Muhle H et al; Environ Health Perspect 102 Suppl 5: 163-8 (1994).
Calcium silicate has been considered as a possible replacement for asbestos due to its heat and fire resistance. The cytotoxic and genotoxic potential of calcium silicate using peripheral human blood lymphocytes is described. Calcium silicates at concn of 10 and 100 ug/ml significantly increased the frequencies of chromosomal aberrations and sister chromatid exchanges. The increases in chromosomal aberrations and sister chromatid exchanges were dose-dependent, though not linearly. A significant decrease in the proliferation rate index was observed with increased dose of calcium silicates. The induction of chromatid type aberrations indicates that the clastogenic activity of calcium silicate is S-phase-dependent.
PMID:7683767 Aslam M, Rahman Q; Mutat Res 300 (1): 45-8 (1993)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
A Calsil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calsil, including repackagers and relabelers. The FDA regulates Calsil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calsil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Calsil supplier is an individual or a company that provides Calsil active pharmaceutical ingredient (API) or Calsil finished formulations upon request. The Calsil suppliers may include Calsil API manufacturers, exporters, distributors and traders.
click here to find a list of Calsil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calsil DMF (Drug Master File) is a document detailing the whole manufacturing process of Calsil active pharmaceutical ingredient (API) in detail. Different forms of Calsil DMFs exist exist since differing nations have different regulations, such as Calsil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calsil DMF submitted to regulatory agencies in the US is known as a USDMF. Calsil USDMF includes data on Calsil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calsil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calsil suppliers with USDMF on PharmaCompass.
A Calsil written confirmation (Calsil WC) is an official document issued by a regulatory agency to a Calsil manufacturer, verifying that the manufacturing facility of a Calsil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calsil APIs or Calsil finished pharmaceutical products to another nation, regulatory agencies frequently require a Calsil WC (written confirmation) as part of the regulatory process.
click here to find a list of Calsil suppliers with Written Confirmation (WC) on PharmaCompass.
Calsil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calsil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calsil GMP manufacturer or Calsil GMP API supplier for your needs.
A Calsil CoA (Certificate of Analysis) is a formal document that attests to Calsil's compliance with Calsil specifications and serves as a tool for batch-level quality control.
Calsil CoA mostly includes findings from lab analyses of a specific batch. For each Calsil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calsil may be tested according to a variety of international standards, such as European Pharmacopoeia (Calsil EP), Calsil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calsil USP).
LOOKING FOR A SUPPLIER?
